title: Effect of hydration on methotrexate plasma concentrations in children with acute lymphocytic leukemia.
abstract: Hydration and urinary alkalinization are used with high-dose methotrexate (HDMTX) to minimize renal toxicity resulting from methotrexate (MTX) precipitation in the kidney tubules. The effect of two hydration and alkalinization schedules on MTX plasma concentrations were evaluated in 100 children with acute lymphocytic leukemia (ALL) following two courses of MTX, 2 g/m2. The mean 21- and 44-hour MTX plasma concentrations were significantly lower in the group receiving the greater hydration and alkalinization schedule: 0.79 (0.90 SD) v 1.39 (1.99 SD) mumol/L for 21-hour MTX plasma concentrations, P = .01; and 0.18 (0.38 SD) v 0.25 (0.50 SD) mumol/L for 44-hour MTX plasma concentrations, P = .01. Although the overall incidence of toxic events was similar in both groups, the incidence of severe toxicity was reduced in the group that received the greater hydration and alkalinization, 6% v 16%. This study demonstrated that the amount of hydration and alkalinization can affect MTX plasma concentrations. Optimizing the hydration and alkalinization schedule is important for minimizing the incidence of severe toxicity associated with HDMTX.
authors.affiliation: Pharmaceutical Division, St. Jude Children's Research Hospital, Memphis, TN 38105.
authors.forename: M L
authors.initials: ML
authors.lastname: Christensen
authors.forename: G K
authors.initials: GK
authors.lastname: Rivera
authors.forename: W R
authors.initials: WR
authors.lastname: Crom
authors.forename: M L
authors.initials: ML
authors.lastname: Hancock
authors.forename: W E
authors.initials: WE
authors.lastname: Evans
mesh_terms: D001639:Bicarbonates / Q000008:administration & dosage; D005440:Fluid Therapy; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007945:Leukemia, Lymphoid / Q000097:blood / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood*
chemical_list: D001639:Bicarbonates; D008727:Methotrexate